Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
Novo to gradually phase out production of human insulin pens
As sales of Novo Nordisk’s GLP-1 drugs continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities.
Fraiser Kansteiner
Nov 14, 2024 2:13pm
GAO takes FDA to task over lagging drug plant inspections
Nov 14, 2024 9:05am
Otsuka forms joint venture to boost IV solution supply
Nov 14, 2024 8:40am
Ascend climbs with deal that elevates the CDMO’s US footprint
Nov 14, 2024 8:23am
AZ tacks on $2B to its investment in US manufacturing, R&D
Nov 12, 2024 10:10am
Swiss CDMO Lonza widens its ADC digs with 2028 expansion
Nov 12, 2024 10:00am
